What can a diagnostics company do for antimicrobial stewardship?
Dr. François Lacoste, Executive Vice President, Clinical Unit, bioMérieux, was recently...
Read Moreby bioMérieux | Feb 5, 2019 | In Focus
Dr. François Lacoste, Executive Vice President, Clinical Unit, bioMérieux, was recently...
Read Moreby bioMérieux | Jan 31, 2019 | Solutions
We all know that antimicrobial resistance is continually on the rise. We also know we have to be...
Read Moreby bioMérieux | Mar 12, 2018 | Education
As we face an increasing array of hard-to-treat multidrug resistant infections, it’s become vital...
Read Moreby Steve Michalik | Oct 18, 2017 | Education
In the first installment of this series of articles on MICs (minimum inhibitory concentrations) we...
Read Moreby Vincent J. LaBombardi | Oct 18, 2017 | Education
Do lab processes really help patient care? Dr. Vincent J. LaBombardi and his microbiology team at...
Read Moreby Victoria Girard | Oct 17, 2017 | In Focus
New species of pathogens that can cause more severe infections and exhibit greater resistance to...
Read Moreby Fabienne Combier | Oct 17, 2017 | Solutions
Multi-drug resistant infections (MDRO) have been reducing the world’s antimicrobial arsenal for...
Read Moreby Steve Michalik | Sep 19, 2017 | Education
What if you could get even more out of your VITEK® 2 with the Advanced Expert System™...
Read Moreby Fabienne Combier | Feb 13, 2017 | Solutions
ETEST® Ceftolozane/Tazobactam (C/T 256)* is the new, reliable solution for antibiotic...
Read Moreby Sheila Farnham | Feb 13, 2017 | Education
Over the years, I’ve often been asked if VITEK® 2 provides “real” or “true” MICs. To answer that,...
Read More